FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386989196> ?p ?o ?g. }

• W4386989196 endingPage "e39" @default.
• W4386989196 startingPage "e38" @default.
• W4386989196 abstract "Abstract Background Paediatric iron deficiency anemia (IDA) is a common condition in Canadian children; however, little is known about the natural history of extreme cases. This deficit makes it challenging to determine how to approach management when these patients present acutely to the emergency department (ED). Objectives To describe the clinical features and management of children presenting to the ED with very severe IDA with hemoglobin &lt; 40 g/L. Design/Methods Retrospective chart reviews were performed for paediatric patients with IDA and hemoglobin &lt; 40 g/L over a 5-year period (June 2017 – June 2022) at a Canadian tertiary care children’s hospital. Results Chart reviews were completed for 19 patients. The mean case rate was 3.1 patients annually (SD 2.14) with 11(58%) presenting in 2021–2022. Patients were young (median age 24 months; IQR 18–32) and predominantly female (79%). Nutritional deficiencies were the most common etiology (n=16, 84%). Median presenting hemoglobin was 25 g/L (IQR 22–36 g/L). The most common clinical features documented at presentation were pallor (n=19, 100%), tachycardia (n=17, 89%), and systolic ejection murmur (n=14, 74%). Thirteen (68%) patients had a ferritin measured in ED, 11(58%) had a chest x-ray, four (21%) had a lactate measured. One (5%) patient had an echocardiogram, and four (21%) had bedside cardiac ultrasounds documented. Eight (42%) patients with median hemoglobin 35 g/L (IQR 25–36 g/L) were managed without blood transfusion (PO iron only: n=3, 16%; IV iron only: n=5, 26%). Of the 11 (63%) patients who received blood, 2 (18%) had transfusion-related adverse events, with one patient undergoing intubation for transfusion-associated circulatory overload while admitted. All patients (100%) were initiated on oral iron supplementation. Ten patients (53%) received intravenous (IV) iron (dose 5–7 mg/kg) with one experiencing a mild reaction. Fifteen patients (79%) were hospitalized, with two (10%) admitted directly to the Paediatric Intensive Care Unit. Median duration of hospitalization was 5 days (IQR 2–9 days). Patients followed after transfusion-free management (n=5) demonstrated median hemoglobin increase of 21 g/L (IQR 20–32 g/L) within 12 days. No patient returned to the ED for anemia within 30 days. Conclusion Paediatric patients with very severe IDA do not always require transfusion. Some patients were effectively managed with IV iron alone. Investigation and management of these patients appears heterogenous. Given the risks of blood transfusion and the increased availability of IV iron, guidelines outlining evidence-based management of severe IDA are needed. These guidelines should promote optimization of iron therapy and guide judicious administration of blood transfusion." @default.
• W4386989196 created "2023-09-24" @default.
• W4386989196 creator A5018330264 @default.
• W4386989196 creator A5074352271 @default.
• W4386989196 creator A5087384407 @default.
• W4386989196 creator A5090763937 @default.
• W4386989196 date "2023-09-01" @default.
• W4386989196 modified "2023-10-18" @default.
• W4386989196 title "82 Management of Very Severe Iron Deficiency Anemia: Is Transfusion Always Necessary?" @default.
• W4386989196 doi "https://doi.org/10.1093/pch/pxad055.082" @default.
• W4386989196 hasPublicationYear "2023" @default.
• W4386989196 type Work @default.
• W4386989196 citedByCount "0" @default.
• W4386989196 crossrefType "journal-article" @default.
• W4386989196 hasAuthorship W4386989196A5018330264 @default.
• W4386989196 hasAuthorship W4386989196A5074352271 @default.
• W4386989196 hasAuthorship W4386989196A5087384407 @default.
• W4386989196 hasAuthorship W4386989196A5090763937 @default.
• W4386989196 hasBestOaLocation W43869891961 @default.
• W4386989196 hasConcept C118552586 @default.
• W4386989196 hasConcept C126322002 @default.
• W4386989196 hasConcept C137627325 @default.
• W4386989196 hasConcept C187212893 @default.
• W4386989196 hasConcept C2776732101 @default.
• W4386989196 hasConcept C2778124894 @default.
• W4386989196 hasConcept C2778248108 @default.
• W4386989196 hasConcept C2778917026 @default.
• W4386989196 hasConcept C2780724011 @default.
• W4386989196 hasConcept C71924100 @default.
• W4386989196 hasConceptScore W4386989196C118552586 @default.
• W4386989196 hasConceptScore W4386989196C126322002 @default.
• W4386989196 hasConceptScore W4386989196C137627325 @default.
• W4386989196 hasConceptScore W4386989196C187212893 @default.
• W4386989196 hasConceptScore W4386989196C2776732101 @default.
• W4386989196 hasConceptScore W4386989196C2778124894 @default.
• W4386989196 hasConceptScore W4386989196C2778248108 @default.
• W4386989196 hasConceptScore W4386989196C2778917026 @default.
• W4386989196 hasConceptScore W4386989196C2780724011 @default.
• W4386989196 hasConceptScore W4386989196C71924100 @default.
• W4386989196 hasIssue "Supplement_1" @default.
• W4386989196 hasLocation W43869891961 @default.
• W4386989196 hasOpenAccess W4386989196 @default.
• W4386989196 hasPrimaryLocation W43869891961 @default.
• W4386989196 hasRelatedWork W117752775 @default.
• W4386989196 hasRelatedWork W22040025 @default.
• W4386989196 hasRelatedWork W2209912724 @default.
• W4386989196 hasRelatedWork W2372991586 @default.
• W4386989196 hasRelatedWork W2615428502 @default.
• W4386989196 hasRelatedWork W3211676710 @default.
• W4386989196 hasRelatedWork W34678310 @default.
• W4386989196 hasRelatedWork W4313387158 @default.
• W4386989196 hasRelatedWork W4313421786 @default.
• W4386989196 hasRelatedWork W2480594226 @default.
• W4386989196 hasVolume "28" @default.
• W4386989196 isParatext "false" @default.
• W4386989196 isRetracted "false" @default.
• W4386989196 workType "article" @default.